Bevacizumab in combination with FOLFIRI in metastatic colorectal cancer: A retrospective study of adverse events and their correlation with clinical outcome.
John Gordon Lenehan
No relevant relationships to disclose
Mary J. MacKenzie
Honoraria - Roche
Mark David Vincent
Honoraria - Roche
Stephen Welch
Honoraria - Roche